top of page
Upcoming Events

Membership Offer



Backing, building and exiting: what the BioInvest Catalyst Dinner revealed about life sciences capital
On Wednesday 28 October, BioNSW members filled The Oriana for the BioInvest Catalyst Dinner, a candid evening with people who have backed, built and exited life sciences companies. The case study was Tetratherix (ASX: TTX). The Sydney medtech grew out of research at the University of Sydney and listed on the ASX in June 2025. It raised $25 million at $2.88 a share, valuing the company at $145 million. It was also a deliberate choice to raise less: CEO Will Knox cut the IPO fr


66 Leaders, One Message: NSW Life Sciences Manufacturing Is Ready to Move
Last Thursday 15 October, 66 people from across industry, academia and the life sciences ecosystem gathered at Macquarie University Incubator for the NSW Advanced Manufacturing Breakfast Forum, hosted by BioNSW. The question on the table: how can NSW strengthen its sovereign manufacturing capability and build a globally competitive life sciences ecosystem? A full room at a free event shows how much interest there is in life science manufacturing in NSW. The morning was chaire


Commercialisation and Innovation Breakfast, Hype, Hope and What's Next
Hype, Hope and a Coffee Order BioNSW's Commercialisation Breakfast put an IP specialist, two investors, a medtech industry veteran and clinician, together with a university dean in one room to sort genuine innovation from noise. The line that stuck wasn't about a technology at all. “Go and buy people coffee. Make friends. Put yourself in their line of sight.” That was Mark Flynn's advice to a room full of researchers and founders on 8 September, and it had nothing to do with
Our Past Events At A Glance
bottom of page
